FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/04/065937 [Registered on: 18/04/2024] Trial Registered Prospectively
Last Modified On: 15/04/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Preventive
Other (Specify) [Procedural Analgesia]  
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   Preventing procedural pain in preterm infants during Retinopathy of Prematurity screening. 
Scientific Title of Study   Procedural analgesia for pain during retinopathy of prematurity screening in preterm infants: A Multi-arm, Parallel group, Randomized Controlled trial comparing Multisensory stimulation, oral paracetamol, and control 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Mounika B 
Designation  PG Student  
Affiliation  Instiute of Child Health and Hospital for Children, Madreas Medical College.  
Address  Department of Neonatology, ICH and HC, Madras Medical College, Tamil Salai, Egmore, Chennai-600008
Department of Neonatology, ICH and HC, Madras Medical College, Tamil Salai, Egmore, Chennai-600008
Chennai
TAMIL NADU
600008
India 
Phone  8123705285  
Fax    
Email  mounabhaskarnaidu@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  KAMALARATNAM C N 
Designation  Professor of Neonatology 
Affiliation  Institute of Child Health and Hospital for Children, Madras Medical College, Chennai 
Address  Department of Neonatology, A-Block, 1st floor, ICH & HC, Egmore Tamil Salai Chennai

Chennai
TAMIL NADU
600008
India 
Phone  9841102746  
Fax    
Email  drkamal.rathnam@gmail.com  
 
Details of Contact Person
Public Query
 
Name  KAMALARATNAM C N 
Designation  Professor  
Affiliation  Institute of Child Health and Hospital for Children, Madras Medical College, Chennai 
Address  Department of Neonatology, A-Block, 1st floor, ICH & HC, Egmore Tamil Salai Chennai
Department of Neonatology, A-Block, 1st floor, ICH & HC, Egmore Tamil Salai Chennai
Chennai
TAMIL NADU
600008
India 
Phone  9841102746  
Fax    
Email  drkamal.rathnam@gmail.com  
 
Source of Monetary or Material Support  
SELF. Dr Mounika B, PG Student, Department of Neonatology, A-block, 1st floor, Institue of Child Health and Hospital for Children, Tamil Salai, Egmore, Chennai- 600008 
 
Primary Sponsor  
Name  DR MOUNIKA B  
Address  Department of Neonatology, 1s floor, A- Block, Institute of Child Health & Hospitalfor Children, Tamil Salai, Egmore, Chennai- 600008 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR MOUNIKA B  Institute of Child Health and Hospital for Children  Department of Neonatology, A-block, 1st floor, ICH and HC, Tamil Salai, Egmore-600008
Chennai
TAMIL NADU 
8123705285

mounabhaskarnaidu@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE, MADRAS MEDICALCOLLEGE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H36||Retinal disorders in diseases classified elsewhere,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  1. Multisensory Stimulation   1. MSS: - Before engaging in stimulations, the mother will be trained by the researcher on the correct methods of performing the interventions using videos and demonstrations over the mannequin. - At first, the infant will be placed in a supine position with hands and legs bent as in fetal position. - For tactile stimulation - the face, upper, and lower limbs of the infant will be gently touched by the other, performed from 20 minutes before the beginning of examination until the time of examination. - For hearing stimulation - the mother will be asked to speak or sing a lullaby to her baby gently and continuously. This intervention will be performed from 20 minutes before the beginning of the examination until the time of the examination. - For olfactory stimulation – 1 % Vanilla solution will be stained in a piece of sterile gauze and held close to the infant’s nose without any contact, at an average distance of 1 to 2 mm. This intervention will be performed from 20 minutes before the beginning of the examination until the time of the examination. - For taste stimulation – o.5 ml/kg of EBM shall be drawn into a syringe by the researcher. The syringe mouth without a needle was placed into the infant’s mouth and the solution will be injected into the infant’s mouth with gentle movements along with the infant’s sucking for 30 seconds. This intervention will be started 2 minutes before the examination. - For visual stimulation - the mother will be asked to look at her baby from nearby and try for eye communication to attract the infant’s attention. This intervention will be performed from 20 minutes before the beginning of the examination until the time of the examination. However, since the infant’s eyes will be dilated, the effect of this visual stimulation is unreliable.  
Intervention  2. Oral Paracetamol  A dose of 15 mg/kg will be administered orally 60 min before the procedure along with the standard care. 
Comparator Agent  Control  Standard care of combination of topical anesthetic eye drops (0.5% proparacaine) 30 seconds before examination combined with swaddling of the infant. A mydriatic combination of tropicamide 0.8% with Phenylephrine 0.5% 1 drop in each eye will be instilled every 10–15 min four times starting 1hr before the scheduled time for the examination. After instilling 1 drop of topical anesthetic, 0.5 % Proparacaine, a wire speculum will be inserted to keep the eyelids apart and an examination will be done by a senior ophthalmologist using the wide-angle digital retinal camera. All the procedures in this study will be done by the same trained ophthalmology technician and all neonates will receive standard care during the examination. Video recordings will be done using a tripod and camera capturing the baby and pulse-oximeter, starting from 1min before 1-hour post-procedure. 
 
Inclusion Criteria  
Age From  14.00 Day(s)
Age To  60.00 Day(s)
Gender  Both 
Details  1. Neonates who will be undergoing ROP screening as per ILROP-3 recommendation for the first time. 
 
ExclusionCriteria 
Details  1. Infants with IVH 3 or more
2. Infants on a mechanical ventilator, inotropes, sedatives
3. Infants who underwent any surgery
4. Major congenital anomalies - cardiac, neurological, facial palsy
5. Those infants whose mothers will not be available during the intervention
6. Infants whose parents do not consent to participate in the trial
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
1. To compare the mean scores of pain severity of MSS and the Control group using the PIPP-R scale during the below 10 described stages.

2. To compare the mean scores of pain severity of oral Paracetamol and the Control group using the PIPP-R scale during the below 10 described stages.

2. To compare the mean scores of pain severity of oral Paracetamol and the Control group using the PIPP-R scale during the below 10 described stages.
 
- 30 seconds before examination
- During the examination of the 1st eye
- During the examination of the 2nd eye
- 30 seconds after the end of the examination
- 1 minute after the end of the examination
- 1.5 minutes after the end of the examination
- 2 minutes after the end of the examination
- 5 minutes after the end of the examination
- 30 minutes after the end of the examination
- 1 hour after the end of the examination
 
 
Secondary Outcome  
Outcome  TimePoints 
1. To compare the mean scores of pain severity between the MSS and oral Paracetamol groups using the PIPP-R scale during the 10 described stages  - 30 seconds before examination
- During the examination of the 1st eye
- During the examination of the 2nd eye
- 30 seconds after the end of the examination
- 1 minute after the end of the examination
- 1.5 minutes after the end of the examination
- 2 minutes after the end of the examination
- 5 minutes after the end of the examination
- 30 minutes after the end of the examination
- 1 hour after the end of the examination
 
2. To compare the trend of mean scores of pain severity using the PIPP-R scale of all the three groups during the 10 described stages.  - 30 seconds before examination
- During the examination of the 1st eye
- During the examination of the 2nd eye
- 30 seconds after the end of the examination
- 1 minute after the end of the examination
- 1.5 minutes after the end of the examination
- 2 minutes after the end of the examination
- 5 minutes after the end of the examination
- 30 minutes after the end of the examination
- 1 hour after the end of the examination
 
3. To compare the mean pain scores using the NIPS Pain Scale- Between MSS and control groups; Between oral paracetamol and control groups; Between MSS and oral paracetamol groups
 
- 6 hours post procedure
- 12 hours post procedure
- 24 hours post procedure
- 36 hours post procedure
- 48 hours post procedure
 
4. To compare the total cry time post-procedure- Between MSS and control groups; Between oral paracetamol and control groups; Between MSS and oral paracetamol group
 
Total cry time post-procedure 
 
Target Sample Size   Total Sample Size="150"
Sample Size from India="150" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   26/04/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [mounabhaskarnaidu@gmail.com].

  6. For how long will this data be available start date provided 15-08-2025 and end date provided 14-08-2028?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  

­Screening for Retinopathy of prematurity (ROP) in preterm infants is one of the most painful procedures. Non-pharmacological methods like, expressed breast milk (EBM), non-nutritive sucking (NNS), facilitated tucking, and swaddling, and pharmacological methods like topical analgesia alone or with oral paracetamol, intranasal fentanyl, and morphine have been studied for analgesia for pain during ROP screening. 

Previous studies (only 4 studies) on oral paracetamol for pain during ROP screening, have shown varied results from significant to no effect. As per our literature search till now, there are very few (Only 2) studies on the effect of Multi-Sensory Stimulation (MSS) on pain during ROP screening. Also, we could not find any studies comparing the efficacy of the non-pharmacological modality of MSS versus oral Paracetamol for pain during ROP screening. Hence, this multi-arm trial aims to study the effect of MSS and oral Paracetamol against the control of Topical analgesia, which is a standard recommendation by various governing bodies, and also compare the efficacy of efficacy non-pharmacological modality of MSS versus oral Paracetamol for pain during ROP screening.

 
Close